<DOC>
	<DOC>NCT00444821</DOC>
	<brief_summary>The purpose of this study is to compare endovascular repair using any FDA approved Medtronic AAA Stent Graft System versus surveillance in subjects with smaller abdominal aortic aneurysms (AAA)(4-5CM), with respect to AAA rupture and AAA related deaths.</brief_summary>
	<brief_title>The (PIVOTAL) Study</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
	<criteria>40 to 90 years of age Meet all indications for use as stated in the Medtronic Vascular AAA Endograft Instructions for Use If female patient with child bearing potential, must have a documented negative pregnancy test within seven(7)days prior to inclusion Patient is willing and able to comply with the specified followup evaluation Life expectancy at least 3 years Meet any of the Contraindications stated in the Medtronic Vascular AAA Endograft instructions for Use Known coexisting condition with a life expectancy of less than 3 years Major surgical or interventional procedure (vascular and/or nonvascular)within 30 days prior to study enrollment Subjects enrolled in another clinical trial or anticipated to be included into a trial, which may interfere with this study, or subjects already enrolled in this trial before. Planned conduit procedure for introduction of endograft</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>AAA</keyword>
	<keyword>Aneurysm</keyword>
	<keyword>AneuRx</keyword>
	<keyword>Talent</keyword>
</DOC>